Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A mouse model for visualization and conditional mutations in the erythroid lineage.

Achim C Heinrich1, Roberta Pelanda, Ursula Klingmüller

  • 1Max-Planck-Institute für Immunbiologie, Freiburg, Germany.

Blood
|April 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer.

Cell death and differentiation·2026
Same author

Models of the human heart for biomedical research: Opportunities and challenges.

Physiological reports·2026
Same author

What questions currently beyond reach do you hope systems approaches will enable addressing in the next decade?

Cell systems·2026
Same author

SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease.

Scientific reports·2025
Same author

Diclofenac and acetaminophen dim the acute-phase response but amplify expression of the iron regulator hepcidin in liver cancer cells.

Cell systems·2025
Same author

Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark set.

Nature communications·2025
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Researchers developed a new mouse model (ErGFPcre) for studying blood disorders. This model allows precise genetic modification of erythroid progenitor cells, aiding in understanding disease mechanisms and EpoR gene regulation.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Hematologic disorders arise from genetic mutations, but their pathogenic mechanisms are not fully understood.
  • Conditional gene manipulation using the Cre-loxP system is crucial for generating accurate mouse models.

Purpose of the Study:

  • To establish a novel knock-in mouse model (ErGFPcre) for identifying and genetically manipulating erythroid progenitor cells.
  • To investigate the developmental progression of erythroid progenitor cells and EpoR expression.

Main Methods:

  • Generation of ErGFPcre knock-in mice expressing an improved GFPcre fusion protein under the endogenous erythropoietin receptor (EpoR) promoter.
  • Analysis of GFP expression in erythroid progenitor cells and assessment of Cre-mediated recombination efficiency in adult bone marrow and fetal liver.

Related Experiment Videos

Main Results:

  • ErGFPcre mice successfully identify GFP-positive erythroid progenitor cells and enable specific genomic manipulation of the erythroid lineage.
  • Cre-mediated recombination is highly efficient (up to 80% in adult bone marrow, ~100% in fetal liver) within erythroid progenitor cells.
  • A developmental switch in lineage progression was observed, identifying early erythroid progenitor cells as Sca-1(-) and c-kit(high).
  • Differential transcriptional activity between wild-type and knock-in loci was noted in nonhematopoietic tissues.

Conclusions:

  • The ErGFPcre mouse model is a valuable tool for characterizing erythroid progenitor cells and facilitating their genomic manipulation.
  • This model can advance the understanding of regulatory elements controlling nonhematopoietic EpoR expression.
  • The findings contribute to elucidating the molecular mechanisms underlying hematologic disorders.